Health Care·Life Sciences Tools & Services·$32.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.63 | N/A | -5.26% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.63 | N/A | -5.26% |
| Revenue | N/A | N/A | N/A |
Tone: Neutral
Management maintained a neutral stance without offering specific guidance. They highlighted their focus on long-term strategies.
Management did not provide specific insights into revenue performance.
The company emphasized ongoing strategic initiatives.
Agilent Technologies reported an EPS of $0.63, slightly missing expectations. The stock reacted by declining 0.38%, indicating investor caution. The lack of revenue data and guidance may have contributed to the muted response from the market.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AMERICAN FINL GROUP
Feb 11, 2013